Serum programmed cell death proteins in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a multifactorial, multisystem pro-inflammatory neuromuscular disorder. Activation of programmed cell death-1 (PD-1), and its ligands, programmed cell death-ligand 1 and 2 (PD-L1/L2), leads to immune suppression. Serum soluble forms of these proteins, sPD-1/sPD-...
Main Authors: | David R. Beers, Weihua Zhao, Jason R. Thonhoff, Alireza Faridar, Aaron D. Thome, Shixiang Wen, Jinghong Wang, Stanley H. Appel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Brain, Behavior, & Immunity - Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666354621000120 |
Similar Items
-
Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
by: Giuseppe Schirò, et al.
Published: (2022-10-01) -
Sport and risk of amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2019-01-01) -
Sport and risk of amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2019-01-01) -
Sport and risk of amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2019-01-01) -
A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone
by: Erdi Şahin
Published: (2018-03-01)